Menu
Not yet recruiting NCT07313085

Mechanisms of Fecal Incontinence in Wolfram Syndrome

Observational Wolfram Syndrome Fecal Incontinence

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Retrospective case-control analysis.
Who it may be relevant to
Registry conditions: Wolfram Syndrome, Fecal Incontinence. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Physiopathogenic Mechanisms of Fecal Incontinence in Wolfram Syndrome

Overview

In order to clarify the mechanism of fecal incontinence in in Wolfram syndrome and to characterize its risk factors, the examiner will reviewed the files of patients followed in a Reference Center for Rare Diseases in Ophthalmology.

Interventions

  • Other Retrospective case-control analysis
    retrospective analysis of data

Primary outcome measures

  • Urinary disorders [Time frame: The date at the baseline]
Secondary outcome measures (4)
  • sleep apnea [Time frame: The date the data will be analyzed at the baseline]
  • frequence of swallowing disroder [Time frame: The data will be analyzed at baseline]
  • frequence of diabetes insipidus [Time frame: The data will be analyzed at baseline]
  • mutation type [Time frame: The data will be analyzed at baseline]

Eligibility criteria

Inclusion criteria

  • Wolfram syndrome

Exclusion criteria

  • no information concerning fecal incontinence in data records

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-control

Study locations

France · 1 center
  • HEGP — Paris

Identifiers

NCT: NCT07313085 · FECINCONTWS1125

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗